-
Oncology Drug Approval News Flash: Optune Pax, a low electric field tumor treating fields device, approved with gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer
-
Series: Untangling Cancer Worries — Your First GuidePart 5: Genetic Variants and Cancer Risk — What Tests Can Tell You (and What They Can’t)
-
Series: Untangling Cancer Worries — Your First Guide Part 4: Benign vs Malignant Tumors — What the Words Mean (and What to Confirm First)
-
Series: Untangling Cancer Worries — Your First Guide Part 3: What Does “Metastasis” Mean? How It Differs From Stage—and How Treatment Plans Can Change
-
Oncology Drug Approval News Flash: Pembrolizumab plus paclitaxel with or without bevacizumab approved for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
